Immunotherapy for Untreated, Metastatic NSCLC: Optimising Survival Outcomes
Patient Selection for different treatment strategies in the aim
of improving survival and other important patient outcomes
Dr. Marina Garassino
Head of Thoracic-Pulmonary Oncology
Fondazione IRCCS Institut Nazionale dei Tumori of Milan, Italy
Sunday, February 10th 17:00-20:30
Dan Acadia Hotel, Ramat Yam 122, Herzliya
AGENDA
- 17:00-17:20 Welcome reception
-
17:20-18:05
The New Treatment Paradigm in the Era of Immunotherapy
Dr. Marina Garassino; Head of Thoracic-Pulmonary Oncology,
Fondazione IRCCS Institut Nazionale dei Tumori of Milan, Italy - 18:05-18:15 Break
- 18:15-19:15 IO Discussion on Patient Selection and Patient Management
-
19:15-19:35
Out of the box lecture: Developing resistance to therapy:
Learning from the realm of antibioticsProf. Jihad Bishara Head of Infectious Disease Unit at Rabin Medical Center - 19:35-20:30 Dinner